This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Early Stocks in Motion

Express Scripts (ESRX) after the bell Monday announced that it now expects 2006 earnings of $3.10 to $3.22 a share, including 10 cents in stock option expenses. Analysts polled by Thomson First Call project 2006 earnings of $2.98 a share. The pharmacy benefit manager said its financial performance will benefit from growth in generic utilization and home delivery, lower retail and home delivery costs, and increased productivity and other cost management plans. The company's shares gained $2.49, or 3.1%, to $82.38 in after-hours trading.

Applebee's International (APPB) reported a 0.7% increase in systemwide same-store sales for the November period. Franchise-owned restaurants saw same-store sales rise 1.4%, while same-store sales for company restaurants fell 1.4% amid a decrease in guest traffic. The casual-dining chain said its Midwest and New England markets continued to be weak. The stock was down a penny to $23.28 in after-hours trading.

Inter Parfums (IPAR) announced its 2006 guidance after the bell Monday. The perfume and cosmetics maker said it expects to earn $16.9 million, or 83 cents a share, on sales of $301 million, for the year. The guidance includes about 3 cents a share in costs from stock-options expensing. Analysts on average predict 2006 earnings of 80 cents a share and sales of $305 million. "We are looking for earnings to increase at a faster rate than sales and for 2006 to be a record year for profits as well as sales for Inter Parfums," Jean Madar, chairman and CEO, said in a statement. Inter Parfums shares rose 32 cents, or 2.1%, to $15.75 in after-hours trading.

ViroPharma (VPHM) announced a 7 million-share public stock offering. Underwriters will have a 30-day option to purchase up to an additional 1 million shares. The drug company said the proceeds will be used for general corporate purposes. The stock fell $1.34, or 7.9%, to $15.66 after hours.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs